"The use of dronabinol for the treatment of OSA is a novel indication for an already approved drug and, as such, would only require approval by the FDA of a supplemental new drug application (sNDA)."
Anyone have any idea about the length of time for an sNDA compared to a "normal" NDA process with the FDA?
PS - I remain one of the long time holders of this company. Hopefully, this time something can can going.
Any other jewels of wisdom or information would appreciated. And, many thanks to those of you that have been long time contributors to this Market Board. Well informed persons, I might add. Hopefully, Neuro is still involved and will chime in from time to time.
News 
Market Data 
Discover 
